Canaccord cuts AeroVironment stock price target on contract loss

Space Force issued a formal termination of AeroVironment's SCAR contract; the firm will be repaid allowable costs plus a fixed fee and may re‑compete under revised requirements in ~9 months, likely pushing any SCAR-related revenue into FY2028. Q3 FY2026 revenue was $408M (+38% YoY) vs $478M consensus (miss), EPS $0.64 vs $0.72 expected, and adjusted EBITDA $44.5M vs $64.2M expected; Canaccord cut its price target to $300 (from $330) and Citizens cut to $350 (from $400) while maintaining positive ratings. Stock trades at $221.57 (down 47% from its 52-week high of $417.86, up ~78.7% over the past year); strong liquidity (current ratio 5.51) provides a buffer but near-term outlook and guidance are weakened.

Analysis

This is a classic small-cap defense vendor hitting a binary-program shock: near-term revenue volatility will rise while optionality on a favorable re‑compete remains. That combination compresses multiples for companies with concentrated program exposure even if longer-run TAM and technology reuse are intact, because market participants de‑rate execution risk and push value into contingent outcomes.

Second-order winners are incumbents and primes with scale manufacturing and prime/subcontracting footprints — they can internalize program continuity and margins while offering competitors either buyouts or subcontract work, raising the bar for a standalone boutique to win on price. Component and test-equipment suppliers with diversified defense and commercial end-markets will see lower single-customer revenue volatility compared with niche firms that bespoke-build phased-array subsystems.

Key catalysts and tail risks: near-term catalysts include formal RFP/recompete timing, selection of prime partners, and government budget signposts; negative tails are protest/contract litigation, a multi-year slide in program budgets, or a tech pivot rendering current designs noncompetitive. Time horizons separate cleanly — days/weeks for volatility around quarterly prints, months for recompete developments, and 12–36 months for award conversion and revenue normalization.

Key Decisions for Investors

• Short AVAV vs long LMT (equal-dollar pair) — horizon 3–9 months. Rationale: de-risk by pairing a small-cap binary with a large-cap prime; target 30–40% relative downside for AVAV vs 8–15% upside in LMT. Stop: if AVAV trades +20% from entry or pair outperforms by >15% versus expectation.
• Buy a low-cost long-dated AVAV call spread (e.g., Jan 2027 expiry) sized as a directional option play — horizon 9–15 months. Rationale: asymmetric payoff to capture a favorable recompete win while limiting cash outlay; acceptable max loss = premium paid, potential 3x–5x if program award and margins recover.
• Overweight LHX or other diversified RF/avionics suppliers — horizon 6–18 months. Rationale: selective exposure to subcontractor wins and increased prime outsourcing; target absolute return 8–12% with lower idiosyncratic risk than standalone firms.
• Event-driven hedge: buy protection (OTM puts) on AVAV into next quarterly report and RFP milestone — horizon days–weeks. Rationale: insures against headline-driven gap risk; pay small premium to avoid forced deleveraging on large directional positions.